Management of Uncontrolled Type 2 Diabetes with HbA1c of 8%

Recommended Medication Adjustment

Increase metformin to 1000mg twice daily to maximize the glucose-lowering effect, and titrate the dose gradually by 500mg weekly to minimize gastrointestinal side effects, as recommended by the American College of Clinical Endocrinologists 1

Consider adding a second agent based on patient-specific factors, and the American Diabetes Association recommends adding an SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit, especially for patients with established cardiovascular disease 2
For patients without cardiovascular disease, sulfonylureas are a cost-effective second-line option that can reduce HbA1c by 0.8-1.5%, according to the American Association of Clinical Endocrinologists 3

Reassess HbA1c after 3 months of optimized metformin therapy, and monitor for gastrointestinal side effects during dose titration, as suggested by the Endocrine Society 1
Assess renal function before increasing the metformin dose, as dose adjustments are necessary for patients with eGFR <45 mL/min/1.73m², and consider periodic testing of vitamin B12 levels, especially in patients with anemia or peripheral neuropathy 1